In addition, this study also indicates that aberrant CaMKK2 due to potentially dysregulated Ca2+ homeostasis in the AD may lead to decreased secretion of phosphorylated TF (pH~3-4) in the CSF and serum which can be used as a biomarker. The gene discussed is CAMKK2; the disease is Alzheimer disease.